INNOSTEM

Pharmahungary Group is a preclinical (strong cardiovascular and metabolic platforms) and clinical (focusing on medical device and drug-device combination trials that need sensitive patient population, therefore, strong scientific and regulatory support) CRO with innovative in-house R&D projects open for out-licensing and/or co-development as well. Pharmahungary Group is currently focusing e.g. on the development of stem cell technology for cardiovascular research and development... Please contact us by e-mail. Due to the frequent unsolicited phone calls, we take phone calls scheduled by prior e-mail correspondence only. Thank you for your understanding.

Primary location: Budapest European Union